Wnt/β-catenin signaling mediates the senescence of bone marrow-mesenchymal stem cells from systemic lupus erythematosus patients through the p53/p21 pathway

Quantifying pharmacologic suppression of cellular senescence: prevention of cellular hypertrophy versus preservation of proliferative potential

(2016) Zoya N. Demidenko et al.   Aging-US

Glucocorticoids induce senescence in primary human tenocytes by inhibition of sirtuin 1 and activation of the p53/p21 pathway: in vivo and in vitro evidence

(2013) Raewyn C Poulsen et al.   ANNALS OF THE RHEUMATIC DISEASES

Inhibitory effect of oleanolic acid on hepatocellular carcinoma via ERK–p53-mediated cell cycle arrest and mitochondrial-dependent apoptosis

(2013) Xin Wang et al.   CARCINOGENESIS

The matricellular protein CCN1 suppresses lung cancer cell growth by inducing senescence via the p53/p21 pathway

(2013) Shr-Jeng Jim Leu et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

EphB and Ephrin-B Interactions Mediate Human Mesenchymal Stem Cell Suppression of Activated T-Cells

(2013) Thao M. Nguyen et al.   STEM CELLS AND DEVELOPMENT

Decreased microRNA-142-3p/5p expression causes CD4+ T cell activation and B cell hyperstimulation in systemic lupus erythematosus

(2012) Shu Ding et al.   ARTHRITIS AND RHEUMATISM

Upregulation of p16INK4A promotes cellular senescence of bone marrow-derived mesenchymal stem cells from systemic lupus erythematosus patients

(2012) Zhifeng Gu et al.   CELLULAR SIGNALLING

Gene Expression Profile Reveals Abnormalities of Multiple Signaling Pathways in Mesenchymal Stem Cell Derived from Patients with Systemic Lupus Erythematosus

(2012) Yu Tang et al.   Clinical & Developmental Immunology

Differential effect of allogeneic versus syngeneic mesenchymal stem cell transplantation in MRL/lpr and (NZB/NZW)F1 mice

(2012) Fei Gu et al.   CLINICAL IMMUNOLOGY

Wnt/β-catenin signaling induces the aging of mesenchymal stem cells through promoting the ROS production

(2012) Da-yong Zhang et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Enhanced Apoptosis and Senescence of Bone-Marrow-Derived Mesenchymal Stem Cells in Patients with Systemic Lupus Erythematosus

(2012) Xia Li et al.   STEM CELLS AND DEVELOPMENT

Maintaining embryonic stem cell pluripotency with Wnt signaling

(2011) S. Y. Sokol   DEVELOPMENT

Wnt/β-Catenin Signaling Induces the Aging of Mesenchymal Stem Cells through the DNA Damage Response and the p53/p21 Pathway

(2011) Da-yong Zhang et al.   PLoS One

Allogenic mesenchymal stem cells transplantation in refractory systemic lupus erythematosus: a pilot clinical study

(2010) J. Liang et al.   ANNALS OF THE RHEUMATIC DISEASES

Allogenic bone-marrow-derived mesenchymal stem cells transplantation as a novel therapy for systemic lupus erythematosus

(2010) Huayong Zhang et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Bone Marrow Mesenchymal Stem Cells: Historical Overview and Concepts

(2010) Pierre Charbord   HUMAN GENE THERAPY

Defective phenotype of mesenchymal stem cells in patients with systemic lupus erythematosus

(2010) Y. Nie et al.   LUPUS

Autologous mesenchymal stem cell treatment increased T regulatory cells with no effect on disease activity in two systemic lupus erythematosus patients

(2009) F. Carrion et al.   LUPUS